RecallDepth
Class III Ongoing

Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4

This recall is currently active, issued January 21, 2026. It was issued by Sun Pharmaceutical Industries Inc.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
November 26, 2025
Posted
January 21, 2026
Recall Number
D-0257-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class III Drug recalls